Dr. Vishnu Girish

Qualification

• MBBS – M S Ramaiah Medical College, Bangalore, Karnataka
• MD (General Medicine) – Government Kilpauk Medical College, Chennai, Tamil Nadu
• DM (Hepatology) – Institute of Liver and Biliary Sciences, New Delhi

Experience

• 9 years of experience in Internal Medicine and Hepatology
• Currently Consultant and In-Charge of Hepatology Services at VPS Lakeshore Hospital, Kochi (September 2025 – Present)
• Junior Consultant Hepatologist at Sahyadri Specialty Hospital, Pune (August 2024 – September 2025)
• Senior Resident at Institute of Liver and Biliary Sciences, New Delhi (May 2024 – July 2024)
• Specialist in Internal Medicine at Aster Medicity, Kochi (July 2019 – May 2020)
• Medical Officer at Rajagiri Hospital, Kochi (2015-2016)
• Extensive experience in liver transplant management, critical care hepatology, and advanced endoscopic procedures
• Performed over 3000 endoscopy and colonoscopy procedures, 100+ liver biopsies, 100+ HVPG measurements, and 50+ therapeutic ERCPs
• Skilled in preventive hepatology with special interest in MASLD, AUD, nutritional interventions, and exercise medicine

Areas of Interest

• Metabolic-dysfunction associated steatotic liver disease
• Alcohol associated liver disease, Autoimmune liver disease
• Portal hypertension
• Cirrhosis
• Acute-on-chronic liver failure
• Liver transplantation
• Preventive hepatology
• Endohepatology
• Cirrhosis management
• Hepatocellular carcinoma

Other Information

• Regular reviewer for international hepatology journals
• Co-authored four chapters in: Manual of Toxicology – An Indian Perspective. Chennai: Chess Publications; 2018.
• Also serving as the Editor-in-Chief, Hepatology at StatPearls Publishing, Treasure Island, FL (January 2025 – Present)
• Presented research at many international conferences, including AASLD, EASL, and APASL
• Presented multiple cases on hepatology forums, including ‘Cirrhosis with ascites’ to Prof. Paulo Angeli at DRILLS 2023, ‘Progressive HCC’ to Prof. Yogesh Chawla at ILCC 2023, ‘Immune checkpoint inhibitor-related hepatitis’ to Prof. S K Sarin at CCILBS 2022, and a clinical scenario to Prof. Patrick S Kamath at DRILLS 2022.
• Fluent in five languages: English, Malayalam, Hindi, Kannada, and Tamil